Over-all evaluation of chemotherapy for ovarian cancer.
D000231:Adenocarcinoma, Papillary / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use / Q000633:toxicity; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009365:Neoplasm Regression, Spontaneous; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D013724:Teratoma / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use; D013997:Time Factors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D013852:Thiotepa